WHITE PAPER ON CANCER IMMUNOTHERAPY - CALL OPEN
BioVox is currently developing a White Paper on Cancer Immunotherapy, showcasing innovators and world leaders in this exciting field.
Are you an innovative player and do you want to promote your research and business activities? Join our editorial board, a select group of senior managers from different companies, and take the lead in this in-depth publication.
Get in contact to receive more information!
Through our exclusive collaboration with BioCentury the publication will be available (free of charge) on both the BioVox and BioCentury website. We will distribute it to more than 60,000 relevant professional contacts, including industry and research stakeholders, investors, healthcare providers, press agencies, journalists and patient organizations.
This White Paper provides a targetted audience of life sciences stakeholders with an up to date overview of the field. And it gives your company a unique opportunity to promote your corporate innovations.
Are you interested to join? Let's discuss a collaboration!
Get in contact with Niels De Smet.